Related Experiment Videos
The determination of myeloperoxidase activity in liver
D L Duval1, D Howard, T A McCalden
1Department of Surgery, University of Nevada School of Medicine, Reno 89557-0046.
Abstract:
Myeloperoxidase (MPO) is an enzyme found in granulocytes of neutrophils, but not in mammalian tissues. Previous studies have directly correlated MPO activity with neutrophil accumulation in tissues. This study presents a method for determining MPO activity in liver. Neutrophil accumulation in rat liver was provoked by creating partial ischemia followed by reperfusion. Liver homogenates prepared by a standard procedure showed no MPO activity. The homogenate was applied to Sephadex G100 and DEAE Sepharose CL6B columns which separated MPO activity from inhibitory activity. The inhibitor was identified as catalase based upon its elution from the columns and removal with 3-amino- 1,2,4-triazole (AT), a catalase inhibitor. Based upon these findings, it was determined that full MPO activity can be assayed in unfractionated liver homogenates by first inactivating catalase with AT.
Insights
This study introduces a novel method to measure myeloperoxidase (MPO) activity in liver tissue. By inhibiting catalase, researchers can accurately quantify MPO, an important marker for neutrophil accumulation.
Area of Science:
- Biochemistry
- Immunology
- Pathology
Background:
- Myeloperoxidase (MPO) is a key enzyme in neutrophils, crucial for inflammatory responses.
- MPO activity is a recognized indicator of neutrophil infiltration in tissues.
- Assaying MPO in liver homogenates has been challenging due to inhibitory factors.
Purpose of the Study:
- To develop a reliable method for quantifying MPO activity in rat liver.
- To identify and overcome inhibitors of MPO in liver tissue.
- To establish a simplified assay for MPO in unfractionated liver homogenates.
Main Methods:
- Induction of neutrophil accumulation in rat liver via ischemia-reperfusion.
- Fractionation of liver homogenates using Sepharose and DEAE Sepharose chromatography.
- Identification of catalase as an MPO inhibitor.
- Inactivation of catalase using 3-amino-1,2,4-triazole (AT).
Main Results:
- Standard liver homogenates exhibited no detectable MPO activity.
- Chromatography separated MPO activity from an inhibitory substance.
- The inhibitor was identified as catalase.
- Inactivation of catalase with AT enabled accurate MPO activity measurement in unfractionated homogenates.
Conclusions:
- Catalase effectively inhibits MPO activity in liver homogenates.
- A simple method involving catalase inhibition with AT allows for MPO assay in unfractionated liver.
- This technique facilitates the study of MPO as a biomarker for neutrophil-related liver conditions.